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Abstract Muscle stem cell (satellite cell) activation
post muscle injury is a transient and critical step in muscle
regeneration. It is regulated by physiological cues, signal-
ing molecules, and epigenetic regulatory factors. The
mechanisms that coherently turn on the complex activation
process shortly after trauma are just beginning to be illu-
minated. In this review, we will discuss the current
knowledge of satellite cell activation regulation.
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Introduction
Skeletal muscle is voluntarily controlled striated muscle
tissue that produces locomotion, postural behavior, and
breathing. It is also the largest insulin-stimulated glucose
utilization tissue in the body [1]. As the most abundant
tissue in the human body, on average, it accounts for
40–50 % of an adult male’s and 30–40 % of an adult
female’s body weight. Maintenance of muscle mass is not
only critical for precise movements, but also important for
optimal metabolic homeostasis. Unfortunately, due to the
function and location of skeletal muscle, it is susceptible to
the damage caused by overstretching, straining, trauma,
everyday wear and tear, and several degenerative muscle
disorders. These damages can be repaired through muscle
regeneration mediated by muscle stem cells. Satellite cells
represent a major group of muscle stem cells. Initially
identified by Mauro [2] in 1961, satellite cells are located
between the sarcolemma and the basal lamina of myofibers.
These cells usually remain quiescent with a large nuclear-
to-cytoplasmic ratio and a low number of mitochondria [3].
In response to exercise and injury, quiescent satellite cells
are activated to enter the cell cycle, proliferate, and even-
tually exit at G1, fusing to form terminally differentiated
multinucleated myofibers.
In addition to satellite cells, several other types of
muscle-resident adult stem cells have recently been found
[3]. These stem cells are also capable of muscle lineage
differentiation and their activation also represents an
important part of muscle regeneration, although the regu-
latory mechanism remains largely unknown.
There are many sophisticated reviews on satellite cells
and muscle regeneration [3–12]. Here, we summarize the
current literature on regulation of satellite cells and other
muscle-resident stem cell activation.
Satellite cells and satellite cell activation
Although multiple types of stem cells with muscle lineage
differentiation potential have been identified [13], satellite
cells are the major contributor to the remarkable regener-
ative capabilities of skeletal muscle. Satellite cells were
initially discovered by Alex Mauro more than 50 years ago
using electron microscopy, as mononucleated cells located
at the periphery of muscle fibers [2]. Mauro suggested that
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satellite cells ‘‘might be pertinent to the vexing problem of
skeletal muscle regeneration’’ [2]. Indeed, later experi-
ments revealed that satellite cells were able to give rise to
terminally differentiated multinucleated myotubes through
cell fusion to regenerate damaged myofibers [14–20].
During embryonic development, satellite cells emerge
together with the muscle in which they reside and share the
same origin as muscle. Satellite cells from the trunk and
limb muscles originate from the dermomyotome, while the
majority of the satellite cells of the craniofacial muscles are
derived from the head mesoderm [4, 21–24]. The number
of satellite cells reaches a peak at the neonatal stage,
accounting for about 30–35 % of the total myofiber nuclei.
The number decreases to *2–7 % of the total myofiber
nuclei in adulthood [25–29].
Satellite cells are activated and are more proliferative
during the neonatal period to support the rapid gain in
muscle mass [25, 30–32]. In contrast to the situation in
neonates, the majority of satellite cells are mitotically
quiescent in adults, remaining at the G0 stage, although the
mechanism by which active satellite cells become quies-
cent after the burst of postnatal muscle mass growth is not
clear yet.
The quiescent satellite cells reside in a unique niche
in intact muscles [5]. They are located closely
juxtaposed between the sarcolemma of muscle fibers
and the basal lamina that surrounds the fiber [2]. These
cells display specific gene expression profiles compared
to actively proliferating satellite cells. Pax7, Pax3,
M-cadherin, Syndecan-4, CD34, a7-Integrin, and
CXCR4 [33–35] dominantly express in quiescent
satellite cells (Fig. 1), and MyoD expression is absent
in quiescent satellite cells [36, 37]. They can be quickly
activated to re-enter the cell cycle and proliferate in
response to extrinsic signals, a process referred to as
satellite cell activation.
The morphology of activated satellite cells is different
from that of quiescent satellite cells. Quiescent satellite
cells are usually spindle-shaped with little cytoplasm and
few organelles [38, 39], whereas activated satellite cells are
larger with an expanded cytoplasm and more organelles
[39, 40]. The earliest marker for activated satellite cells is
phosphorylated p38, followed by MyoD [41–43]. Although
detected in the majority of quiescent satellite cells, Myf5 is
highly upregulated on activation [44, 45]. During G1
phase, shortly after exit from quiescence, MyoD does not
promote differentiation, but instead directly regulates the
expression of Cdc6, a gene involved in rendering chro-















































Fig. 1 Regulation of satellite cell activation. Satellite cell specific
surface markers were indicated on the cell membrane. Key transcrip-
tion factors involved in satellite cell activation were indicated in the
nuclei of satellite cell. Key signaling pathways regulating satellite cell
activation were listed. Major microenvironment components includ-
ing extra cellular matrix and neighboring cell types (immune cells and
blood vessels) affecting satellite cell activation were illustrated
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MyoD plays multiple roles at different stages of muscle
differentiation in a context-dependent manner. For exam-
ple, MyoD expressed in quiescent cells has been reported
to inhibit cell proliferation in a differentiation-independent
way [47]. In myoblasts, MyoD can also inhibit cell cycle
entry by the induction of p21 and upregulation of apoptotic
genes [48, 49]. After the first cell division, the proliferative
cells enter the cell cycle and continue to divide every 10 h
[50].
Upon stimulation, such as muscle damage, exercise, or
pathogenic conditions, the satellite cells start to proliferate
and give rise to a myogenic precursor cell population called
myoblasts. Myoblasts can go through several rounds of
amplification, then exit the cell cycle and fuse to each other
or to the existing myofibers to form terminally differenti-
ated myofibers. Some of the progeny of the activated
satellite cells can restore the pool of quiescent stem cells by
asymmetric self-renewal [51]. ERK signaling regulates the
reversible quiescence of a subpopulation of satellite cells
through ERK signaling inhibitor Spry1 [52]. Depletion of
Spry1 in satellite cells increases the number of cells com-
mitted to apoptosis and reduced the number of quiescent
satellite cells after muscle injury reparation, suggesting that
Spy1 is required for reversible quiescence [52]. Activation
of satellite cells is the critical step in the initiation of
muscle regeneration. It is subjected to multiple layers of
tight regulation. Physiological cues, signaling molecules,
and epigenetic regulators are all involved in the orches-
tration of the orderly activation of satellite cells upon
stimulation.
Physiological cues to induce satellite cell activation
Disruption of muscle fibers and basal lamina
The intact myofiber sarcolemma and the basal lamina
provide an important niche to maintain the quiescent state
of satellite cells [11]. They are destroyed in muscle injury,
leading to disruption of the protective niche for quiescent
satellite cells. Damages to the basal lamina destroy the
collagen–laminin network, where satellite cells anchor
themselves through a7/b1 integrins [53]. The mobilization
of satellite cells contributes to their activation. Further-
more, destruction of the sarcolemma and the basal lamina
allows an influx of calcium and the release of hepatocyte
growth factor (HGF) from the extra cellular matrix (ECM)
to directly activate the unprotected satellite cells [54–58].
Muscle damage also generates a large amount of des-
tructed muscle fibers. Selective induction of fiber damage
using bupivacaine, without disruption of the basal lamina
and other cell types, results in elevated satellite cell
activation and proliferation [59], suggesting that the dam-
aged fibers provide signals that activate quiescent satellite
cells. Indeed, these dying fibers produce nitric oxide (NO)
that further activates HGF and downstream signaling to
induce satellite cell activation [58]. Therefore, both dis-
ruption of the protective niche and the factors released by
dying fibers contribute to the activation of quiescent
satellite cells.
Infiltration of immune cells
Muscle injury, stretching, overuse, and degenerative mus-
cle diseases induce the infiltration of large amounts of
immune cells, initiated by early neutrophil invasion and
followed by macrophage infiltration [60–62]. Chemokines,
cytokines, and growth factors produced by macrophages,
together with fibroblasts, attract more circulating inflam-
matory cells, including T cells and B cells. Cytokines,
growth factors, and chemokines secreted by these inflam-
matory cells, such as IL-6 and IFNc, can promote satellite
cell activation and proliferation [50, 63–65]. Inhibition of
inflammation by non-steroidal anti-inflammatory drugs in
humans reduces the number of activated satellite cells, thus
slowing down muscle regeneration [66–68]. Immune cells
and the inflammation reaction followed by immune cell
infiltration provide a microenvironment for satellite cell
activation and proliferation (Fig. 1).
Blood vessels
Upon muscle injury, blood vessels are also severely dis-
rupted. The vascular endothelial cells of damaged vessels
release growth factors such as vascular endothelial growth
factor (VEGF), platelet-derived growth factor (PDGF), and
HGF [13]. These factors promote satellite cell activation
and proliferation [11]. Vascularization and angiogenesis
are essential steps in muscle regeneration. Many growth
factors enriched at the injury site to promote vessel resto-
ration can also promote satellite cell proliferation [69, 70].
The restored blood vessels then signal the activated satel-
lite cells to return to the quiescent state [71].
Communication between satellite cells and blood vessels
can, thus, regulate the dynamic cycle of satellite cell acti-
vation and quiescence maintenance.
Signals to activate satellite cells
Upon muscle injury, a combination of signals is generated
by damaged myofibers, blood vessels, and immune cells to
wake up the quiescent satellite cells. The activated satellite
cells also signal back to the environment to orchestrate
orderly muscle regeneration (Fig. 1).
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HGF
HGF is a mesenchyme-derived heparin-binding glycopro-
tein that regulates cell proliferation, cell survival, cell
motility, and morphogenesis [72]. HGF can bind to the
c-Met receptor to regulate cell growth, cell motility, mor-
phogenesis, and organ regeneration by activating a tyrosine
kinase signaling cascade [73]. Mice deficient in HGF or its
receptor, c-Met, lack all the muscle groups derived from
migratory hypaxial precursor cells [57, 74]. The applica-
tion of exogenous HGF to somites induces ectopic
delamination of myogenic precursor cells into the lateral
plate mesoderm [75, 76]. These results suggest that HGF is
essential in inducing the migration of myogenic precursor
cells in embryonic myogenesis.
Satellite cells express both HGF and c-Met. Muscle cells
and non-muscle cells in close proximity produce and secret
HGF, which is sequestered in the ECM around intact
muscle fibers [39, 54, 58]. Upon muscle damage, HGF is
released from the ECM, promoting the entry of quiescent
satellite cells into cell cycle [54–56]. Satellite cells also
express HGF; therefore, the activation of satellite cells by
HGF can undergo both paracrine and autocrine [56].
The presence of HGF-bound c-Met has been considered
to be the initial step in satellite cell activation [40, 55].
Recently, Rodgers et al. showed that injury-related sys-
temic signals could induce the quiescent satellite cells to
transit from G0 to GAlert. The GAlert cells are primed for
activation. HGF, c-Met, and the downstream mTORC1
signaling are required for this transition [77]. The addition
of HGF to satellite cells cultured with single fibers induces
prominent satellite cell activation [40, 56, 78], further
indicating the pivotal role of HGF in this process. HGF
could respond to weak signals induced by injury and prime
the quiescent satellite cells for the ‘‘alert’’ stage. If the
injury continues and the induced systemic signals cross the
threshold, the alerted satellite cells will be quickly acti-
vated and muscle injury will be efficiently repaired.
The molecular mechanism by which HGF further acti-
vates satellite cells has not been fully elucidated. It may
activate the downstream tyrosine kinase signaling pathway
to alter the expression levels of cell cycle-related genes.
The expression levels of c-fos and c-jun, the early genes of
tyrosine kinase signaling, are rapidly upregulated in satel-
lite cells 3–6 h after muscle injury. This is considered to be
the immediate response to HGF-c-Met-mediated signaling.
Receptor-bound HGF can also increase Twist expression
[79] which further activates EMT (epithelial mesenchymal
transition) [80]. Meanwhile HGF-mediated downregulation
of the protein levels of p27kip1 in a p21Cip1/Waf1-inde-
pendent manner in satellite cells [79], helps the cells to
overcome cell cycle blockage. HGF can activate satellite
cells rapidly after trauma by promoting EMT to release
them from their quiescent prone niche and removing cell
cycle blockages.
NO
NO is a freely diffusible small messenger capable of
pleiotropic cellular functions, such as survival, stress
resistance, and neurotransmission [81]. NO is produced in
skeletal muscle through reactions catalyzed by nitric oxide
synthase (NOS). Within 6 h post-injury, NOS mRNA
levels are significantly increased in both damaged muscle
fibers and the infiltrating macrophages, therefore elevating
the NO levels at the injury site [82–84]. In iNOS(-/-) mice,
satellite cells fail to proliferate and differentiate after injury
[85], suggesting that NO is required for normal muscle
reparation after injury.
NO plays multiple roles during the muscle regeneration
process. At the early stage of muscle damage, it promotes
macrophages to lyse damaged muscle cells in a reactive
oxygen species (ROS)-independent manner to protect cells
from further ROS damage [86], and stimulates the release
of HGF, together with other growth factors and cytokines
to activate satellite cells [87]. At the second stage of
muscle regeneration, NO inhibits neutrophil-mediated lysis
of muscle cells and reduces ROS generated from prolonged
inflammation, protecting the activated satellite cells from
ROS stress and apoptosis [82].
NO activates satellite cells not only by facilitating the
release of HGF, but also by antagonizing the inhibitory
effects of TGF-b on satellite cells. The administration of
L-NAME, an NOS inhibitor, at the injury site in rat muscle
leads to abnormally elevated TGF-b level that induces
fibrosis [88].
IGF and FGFs
Insulin-like growth factor (IGF) is a circulating hormone
critical for development and regeneration of almost every
organ [89]. IGF signaling is initiated by binding of IGF to
the IGF receptor (IGFR) to activate its tyrosine kinase
activity and autophosphorylation, which in turn phosphor-
ylates insulin receptor substrate 1 (IRS-1). Phosphorylated
IRS-1 recruits the regulatory subunit of PI3K and activates
it. Activated PI3K phosphorylates Akt, which then acti-
vates mTOR and p70S6 kinase to turn on the IGF-PI3K/
Akt-mTOR-S6K axis of signaling pathway. This signaling
process has been shown to be important for muscle mass
maintenance [90]. Six IGF binding proteins, named IG-
FBP1-6, bind IGF in the extracellular fluid and the
circulation to further regulate IGF activities [91]. The
expression of IGF and all six IGFBPs has been detected in
regenerating skeletal muscle [92], suggesting their roles in
muscle wound healing.
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Muscle damage induces the expression of alternative
splicing isoforms of IGF named mechano-growth factor
(MGF) and IGF-IEa [93]. MGF is only expressed in the
damaged muscle and its expression is correlated with the
activation of quiescent satellite cells [94]. IGF-IEa is
expressed later than MGF during muscle regeneration,
correlating with myoblast proliferation and differentiation
[95, 96]. MGF elevates the activity of superoxide dismu-
tase, the enzyme required for decreasing the level of ROS
[97], thus protecting the satellite cells from ROS-induced
damage. IGFBP6 is an IGF sequester, which increases the
expression levels of IGF isoforms. However, its expression
level is dramatically decreased at the early stage of muscle
regeneration to allow more IGF available to activate
satellite cells and promote their proliferation [98]. IGF-IR
heterozygous mice display decreased the levels of MyoD
expression and satellite cell activation [99], further con-
firming the importance of IGF in the satellite cell activation
process.
The mechanism of IGF-mediated satellite cell activation
has not been fully elucidated but may involve the upreg-
ulation of Myf5 expression upon injury. After muscle
injury, an influx of calcium triggers calcineurin and cal-
modulin kinase through calcium binding to calmodulin, to
activate Myf5 expression. IGF can activate Myf5 through
the calcium-mediated activation pathway [100]. In addi-
tion, it could also activate Myf5 expression through PI3K/
Akt and ERK signaling pathways [100, 101]. It can also
activate expression of cyclin D2 to promote entry to cell
cycle and cell proliferation through MEK/ERK and PI3K/
AKT signaling pathways in C2C12 cells. IGF2 expression
levels could be regulated by N-cadherin signaling through
activation of p38a and b [102]. An immunoglobulin
superfamily member Cdo can cooperate with the scaffold
protein JLP to increase the level of active p38a and b, thus
increasing the expression level of IGF2 during the myo-
blast differentiation process [103]. The similar mechanism
may also contribute to the activation of satellite cells by
IGF. Another immunoglobulin superfamily member, the
receptor for advanced glycation end-products (RAGE)
activated by HMGB1, also plays an important role in
satellite cell activation. RAGE is transiently expressed in
satellite cells located in injured muscles and represses Pax7
expression through activation of p38-MAPK signaling
[104–107]. Deletion of RAGE in muscles leads to
increased satellite cell number and Pax7 expression level
[106], suggesting that RAGE is required for proper timing
of muscle regeneration. RAGE may also be able to regulate
satellite cell activation by repressing Pax7 expression.
Fibroblast growth factors (FGFs) belong to the family of
heparin-binding circulating mitogens that regulate cell
survival, proliferation, migration, differentiation, and
morphogenesis. The expression of many FGF family
members has been detected in skeletal muscle [108].
Among them, FGF6 has been shown to be expressed pre-
dominantly in myogenic cells, and its expression level is
upregulated during muscle regeneration. In FGF6-/- mice,
the number of activated satellite cells is significantly
reduced and the size of quiescent satellite cells pool
remains constant, suggesting that FGF6 is essential for
satellite cell activation and proliferation [109]. Consistent
with the results from gene knockout experiments, the
addition of exogenous FGF1, 2, 4, 6, or 9 stimulates
satellite cell proliferation significantly in vitro. The stim-
ulating effects of FGF2, 4, 6, and 9 are further enhanced in
combination with HGF [110, 111].
FGFs activate the downstream signaling pathways
through binding to FGF receptor 1–4 (FGFR1-4), which are
transmembrane tyrosine receptors. All four FGFRs are
detected in satellite cells. Among them, FGFR1 and 4 are
the most prominent ones [110]. The expression level of
FGFR1 is significantly upregulated shortly after muscle
injury, correlating with the activation of satellite cells
[110]. Overexpression of FGFR1 facilitates the prolifera-
tion of cultured myoblasts and represses myoblast
differentiation [112]. It may also be able to promote the
proliferation of activated satellite cells.
The binding of FGF to FGFR leads to dimerization and
autophosphorylation of the receptor, followed by activation
of Ras signaling pathways. Overexpression of constitu-
tively activated Ras can bypass FGF, promoting myoblast
proliferation [113]. FGF can also activate MKK-ERK
signaling cascade, facilitating the transition from G1 to S
phase in myoblasts, thus increasing their proliferation
[114]. FGF can also induce the activation of satellite cells
by enhancing the G1-S transition through ERK signaling
pathway.
Similar to IGFs, FGF can also regulate calcium-medi-
ated signaling. IGF enhances intracellular calcium intake in
CD34? satellite cells, as indicated by lighting up cells with
the calcium-sensitive fluorescent dye X-Rhod-1. The ele-
vated intracellular calcium level induced by FGF2 triggers
nuclear translocation of NFATc3 and NFATc2, which
facilitates MyoD expression in satellite cells leading to
their activation. The effects of IGF on the calcium intake of
satellite cells and satellite cell activation are antagonized
by the blockage of the TRPC ion channel [115].
Notch
Notch signaling is one of the major regulatory pathways in
cell fate determination. Notch is a family of transmem-
brane receptors containing four members, Notch1–4. After
binding to its ligands (Delta-like 1, Delta-like 4, Jagged 1,
and Jagged 2), Notch undergoes protease cleavage to free
its intracellular domain, NICD, a transcription coactivator
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that facilitates RBP-J kappa (Rbpj, the Notch target tran-
scription factor) -mediated transcription activation [116,
117]. In embryonic muscle development, Notch signaling
is required for myogenic cell fate commitment and muscle
stem cell maintenance. Notch ligand Delta 1 (Dll1) null
mutant mice displayed hypotrophy due to premature dif-
ferentiation of satellite cells [118]. Consistent with it,
muscle-specific depletion of Rbpj leads to loss of myogenic
stem cells due to increasing differentiation during
embryogenesis [119]. Muscle-specific overexpression of
NICD increases Pax7? muscle stem cell numbers and
maintains these cells in an undifferentiated state [120].
Notch1, 2, 3, Notch/Rbpj targets Hey1, HeyL, and Hes1
are all expressed robustly in quiescent satellite cells. Dis-
ruption of Notch signaling by Rbpj depletion in satellite
cells leads to precocious differentiation and depletion of
satellite cells [121]. All these genetic data support that
Notch signaling is essential for maintenance of satellite cell
quiescence, and it should be downregulated in satellite cell
activation. Indeed, endogenous Notch signaling is dramat-
ically reduced in activated satellite cells isolated from
regenerating muscle, compared with quiescent satellite cells
[121–123]. This reduction in activity occurs within 20 h of
an injury [122]. The first mitosis of activated satellite cells
after injury occurs at about the same time (18-24 h) [50].
The correlation of the timing of Notch signaling downreg-
ulation and the cell cycle entrance of quiescent satellite
cells indicates that these two events may be tightly coupled.
Notch signaling has also been reported to be required for
satellite cell proliferation. An abnormally high numbers of
satellite cells are found in Notch3 knockout mice [124].
Activation of Notch signaling in cultured satellite cells also
promotes proliferation of these cells [125, 126]. These
seemingly contradictory results can be explained by the
presence of two waves of Notch signaling during the
activation of satellite cells. The first wave maintains the
quiescent state of the satellite cells, which is inactivated
upon cell activation. The second wave is turned on at the
proliferative stage of the activated satellite cells. The
changes in Notch signaling levels during muscle regener-
ation support this notion. Notch signaling level decreases
almost immediately after muscle injury when satellite cells
are activated [122], and increases again 4–5 days post-
injury [127].
Most of the current observations about the function of
Notch in satellite cell activation are correlations. Whether
Notch is just a passive downstream responder of satellite
cell activation or actively causes the activation is still under
debating. To clarify this issue, continuous monitoring of
Notch signaling level during the satellite cell activation
process and additional well-controlled manipulations of
Notch signaling at various stages of satellite cell activation
are needed.
Wnt
Wnt proteins are soluble signaling molecules regulating
multiple cellular processes, including cell fate determina-
tion, stem cell proliferation, cell polarity, morphology, and
tumorigenesis. The canonical Wnt signaling cascade is
turned on by the binding of Wnt ligand to transmembrane
receptors Frizzled and low-density lipoprotein receptor-
related protein co-receptor (LRP). Ligand binding stimu-
lates the phosphorylation of Dishevelled (Dsh) and
inactivates GSK3b, triggering the stabilization of the
common downstream Wnt effecter b-catenin. When Wnt
signaling is off, a destruction complex composed of
GSK3b, Adenomatous polyposis coli (APC), and Axin2
associates with b-catenin to drive its ubiquitination and
degradation. When Wnt signaling is on, b-catenin accu-
mulates due to the disassembly of the destruction complex
and is translocated into nucleus to serve as a coactivator for
TCF/LEF transcription factors to activate the expression of
target genes [128].
Wnt signaling is upregulated upon muscle injury. There
is increased TCF reporter activity in myogenic cells two
days post-muscle injury [125]. Exogenous Wnt1, 3a, and
5a promote satellite cell proliferation, whereas Wnt4 and 6
inhibit it [3]. b-catenin can promote satellite cell self-
renewal and prevent immediate satellite cell differentiation
[125, 129, 130]. Consistent with the notion that Wnt pro-
motes satellite cell proliferation, nuclear localization of b-
catenin has been detected only in activated satellite cells
and myoblasts, but not in differentiating muscle cells
(myogenin?). Perplexingly, other observations seem to
oppose the pro-proliferative functions of Wnt. When b-
catenin expression level is reduced by RNAi in satellite
cells, more activated Pax7?MyoD? satellite cells are
observed, whereas constitutive expression of b-catenin
leads to downregulation of MyoD [130], suggesting that b-
catenin inhibits satellite cell activation. In aged mice, ele-
vated serum Wnt level inhibits the proliferation of satellite
cells and directs their fate toward the fibrogenic lineage.
Furthermore, injection of Wnt inhibitors Dkk1 and sFRP3
in aged mice leads to reduction of fibrogenic lineage dif-
ferentiation [131, 132]. These seemingly contradictory
results could be due to different systems used in the
experiments and potentially altered Wnt signaling path-
ways in aged animals.
In addition to the canonical Wnt pathway, Wnt can also
activate Rho/Rac and JNK signaling through crosstalk
mediated via Dsh, to regulate cell polarity [133]. This non-
canonical Wnt signaling functions in satellite cells. Wnt7a
stimulates symmetrical division of satellite cells to expand
the activated satellite cell pool via activation of planar cell
polarity (PCP) signaling. The satellite cell number increa-
ses dramatically upon Wnt7a overexpression, whereas the
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depletion of Wnt7a leads to a marked decrease of satellite
cell number [134]. The expansion of the activated satellite
cell pool induces the expression of fibronectin, which fur-
ther modifies the satellite cell niche and stimulates Wnt7a-
Frizzled 7-PCP signaling to form a feedback loop during
muscle regeneration [135].
Both canonical and non-canonical Wnt are involved in
the regulation of satellite cell activation and proliferation.
Experiments, that can pinpoint Wnt functions at a partic-
ular cell stage, i.e., the initial stage of satellite cell
activation, activated satellite cell stage, myoblast stage etc.,
will help to elucidate the functions of Wnt signaling during
satellite cell activation.
TGF-b
The transforming growth factor beta (TGF-b) superfamily
comprises many secreted factors essential in nearly every
aspect of cellular behavior. It is grouped into subfamilies
based on sequence homology, including the TGF-b, acti-
vin, glial cell line derived neurotrophic factor (GDNF),
growth/differentiation factor (GDF), and bone morphoge-
netic protein (BMP) subfamilies. TGF-b ligands bind to
type I and II serine/threonine kinase cell surface receptors.
Upon ligand binding, the type II receptor phosphorylates
the type I receptor to activate it. The activated type I
receptor subsequently phosphorylates receptor-regulated
Smads (R-Smads), which forms a heterodimer with com-
mon mediator Smad (co-Smad) to mediate its nuclear
translocation and transcription activation [136].
In general, TGF-b signaling plays a negative role in the
regulation of myogenesis by repressing the expression of
MyoD and myogenin [137–140]. It is highly expressed in
quiescent satellite cells and repressing cell cycle progres-
sion [98]. Myostatin is a TGF-b family member expressed
specifically in muscle tissue to prevent muscle growth and
differentiation [141]. Myostatin maintains satellite cell
quiescence and represses satellite cell self-renewal by
inducing p21CIP expression [142]. Myostatin represses the
expression of MyoD to prevent satellite cells from activa-
tion [143]. It can also increase Pax7 expression level
through ERK signaling pathway to help maintaining
satellite cell quiescence [144]. Many growth factors,
including IGF and FGF, as described above, antagonize the
inhibitory effects of TGF-b to activate satellite cells during
muscle regeneration, although the mechanisms remain to
be defined.
TGF-b level is elevated in circulation with aging, pre-
venting satellite cells from entering into cell cycle by
inducing the expression of cell cycle inhibitors such as p15,
p16, p21, and p27 [145]. The injection of an antibody
against TGF-b at the injury site of aged mice rejuvenates
satellite cells by promoting their activation [145].
Extracellular matrix signals
Satellite cells have close contact with ECM. In addition to
intracellular responses to signaling molecules, remodeling
of ECM has been shown to be a critical step in satellite cell
activation. Quiescent satellite cells express ECM compo-
nents such as versican, fibrillin-2, and glypicans. These
ECM proteins bind HGF and other growth factors to lower
their effective concentration around satellite cells. Once
trauma occurs in a muscle, ECM is damaged and the
trapped growth factors are released to activate the quies-
cent satellite cells (Fig. 1).
Syndecans
Heparin sulfate proteoglycans (HSPGs) are composed of
two or three linear polysaccharides covalently attached to
various proteins at the cell surface and in ECM. They act as
adhesion proteins and receptors for many growth factors,
morphogens, and adhesion proteins [146]. Transmembrane
syndecans are one of the major forms of membrane
HSPGs. Satellite cells specifically express syndecan-3 and
-4 [147], which serve as low affinity FGF receptors [148].
Satellite cell activation and proliferation is abolished in
syndecan-4 knockout mice due to loss of MAPK signaling
[149], showing syndecan-4 to be required for satellite cell
activation. Syndecan-4 can also form a co-receptor com-
plex with Frizzled-7 to facilitate Wnt7-mediated non-
canonical Wnt signaling to regulate satellite cell activation
[135]. In contrast, satellite cell activation is accelerated in
syndecan-3 knockout mice, although the cells are arrested
in S phase [149]. Syndecan-3 and -4 may work together to
regulate the coherent chain of reactions during satellite cell
activation and proliferation.
MMPs
Matrix metalloproteinases (MMPs) belong to a family of
zinc-dependent endopeptidases capable of degrading ECM
proteins. In skeletal muscle, MMPs are released at the
reparation site by damaged myofibers or immune cells
recruited by muscle injury [150]. MMP2 is produced by
satellite cells and damaged myofibers [151–153], while
MMP9 is generated by infiltrating leukocytes and macro-
phages [153]. NO induces the increase of the enzymatic
activity and expression levels of MMP2 and MMP9. Both
MMP2 and 9 cleave collagens, laminin, and other ECM
components to release HGF from the sequestered sites to
activate satellite cells [154, 155].
Inhibitors of TIMPs (metalloproteinases) are also
involved in satellite cell activation. TIMP3 is highly
expressed in quiescent satellite cells and downregulated in
activated satellite cells [98]. Consequently, the activity of
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MMP2 is elevated in activated satellite cells [151–153]. In
addition to MMP2, TIMP3 can also repress the activity of
TNF-a converting enzyme to block TNF-a mediated p38
signaling pathway activation and further inhibit satellite
cell activation [156].
Pax7 and Pax3 in satellite cell activation
Pax7 and Pax3 are satellite cell markers. Pax3 is expressed in
satellite cells lying in most trunk and forelimb, but not hindlimb
muscles [157], whereas Pax7 is expressed in satellite cells
resident in all muscles [158]. The expression of Pax7, but not
Pax3, prevents satellite cells from undergoing apoptosis [159].
Heterogeneity has been demonstrated in satellite cells. Some
satellite cells express high levels of Pax7 (Pax7High), whereas
*3 % of satellite cells express low levels (Pax7Low) [98]. The
Pax7High cells take longer to enter the cell cycle after satellite
cell activation [11]. Whether the Pax7High and Pax7Low satellite
cells are activated in distinct patterns remains unclear.
Pax3 and Pax7 can control the expression of Myf5 and
MyoD [160], but how Pax7/3 activates MyoD upon muscle
injury, in particular, the transcriptional regulatory mecha-
nism involved, is not known. Recent work on embryonal
rhabdomyosarcomas has shown that the p38 MAPK sig-
naling pathway mediated by the receptor for advanced
glycation end-products could downregulate Pax7. Pax7
may reduce MyoD level by promoting its degradation in
rhabdomyosarcoma [161]. Whether the similar degradation
of MyoD controlled by Pax7 occurs in satellite cells
remains to be examined. Pax7 has been shown to be able to
activate the transcription of MyoD and Myf5 during
embryonic development and in primary myoblasts [157,
160]. Whether Pax7-mediated MyoD degradation also
occurs in satellite cells, in particular at the transition from a
quiescent to an activated cell, requires further study. In
addition, the relationship between Pax7’s role as a tran-
scriptional activator of MyoD, and Myf5 expression and its
function as a factor promoting MyoD degradation, are of
interest and should be further explored.
Inhibitor of DNA binding (Id) proteins are negative regu-
lators of MyoD [162]. Pax7 can also regulate the expression of
Id proteins [163]. Sine oculis homeobox (Six) homeodomain
transcription factors are also involved in satellite cell activa-
tion by regulating MyoD expression [164]. Six1 activates
MyoD expression by directly binding the MyoD promoter
[165]. MyoD expression is diminished by conditional deple-
tion of Six1 in Pax7-expressing satellite cells [166].
Satellite heterogeneity and satellite activation
Satellite cells are heterogeneous cell populations. They
have various developmental origins, fiber associations, and
expression profiles [10]. For example, the expression level
of Pax7 varies dramatically in distinct subgroups of satel-
lite cells. Pax7High cells display reduced metabolic activity
and delayed entrance into cell cycle upon stimulation,
whereas Pax7Low cells are more primed be activated [12].
A small proportion of quiescent satellite cells do not
express CD34 and Myf5 [167], although the physiological
significance of this has not been elucidated. The hetero-
geneity of satellite cells could affect the dynamics of
satellite cell activation.
Myoblasts expressing desmin, MyoD, and myogenin
have been observed within 12 h post-injury, when satellite
cell activation is incomplete and proliferation has not yet
been initiated [168]. The presence of the apparently dif-
ferentiated myoblast population before satellite cell
activation and proliferation could suggest the existence of
two distinct satellite cell populations, the normal quiescent
satellite cells and another group of more ready to differ-
entiate [168]. Each population might be activated through
different signaling pathways and display distinct kinetics.
Identification of markers for each satellite cell subpopula-
tion and development of methods for the specific isolation
of each subpopulation will contribute to elucidate the
specific activation mechanism governing each subpopula-
tion. The accumulation of genomewide profiling at the
single cell level will further deepen our understanding of
the activation of heterogeneous satellite cells.
Epigenetic regulation in satellite cell activation
Histone modifications
Changes in histone modifications on Pax7, MyoD, Myf5,
and other MRF genes occur during muscle regeneration.
The Polycomb group (PcG) and Ttrithorax group (TrxG)
epigenetic regulators play important roles in satellite cell
activation and differentiation. PcG is composed of PRC1
and PRC2 complexes. KMT6, Ezh1, and Ezh2 are subunits
of these two complexes with lysine methyltransferase
activities. MLL1, MLL2, MLL3, MLL4, SET1a, and
SET1b are subunits of TrxG complex with lysine methyl-
transferase activities. PcG marks chromatin with repressive
H3K27me3 modification through its lysine methyltrans-
ferase activities whereas TrxG establishes the permissive
H3K4me3 modification on chromatin [169, 170]. The
transition from the transcriptionally permissive H3K4me3
modification to the repressive H3K27me3 modification is
critical in cell fate determination [170]. This transition is
induced by Ezh2 on the Pax7 gene upon satellite cell
activation and during the subsequent proliferation stages,
switching off Pax7 expression in a p38-MAPK-dependent
manner [171]. The genes involved in cell cycle progression
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are also enriched for the permissive H3K4me3 modifica-
tion in activated satellite cells [172].
Pax7 also participates in the establishment of the epige-
netic pattern in satellite cell activation. In activated satellite
cells and myoblasts derived from satellite cells, Pax7 recruits
the Wdr5-Ash2L-MLL2 histone methyltransferase complex
that methylates the H3K4 site to establish a permissive
H3K4me3 modification on Myf5 [173].
A genomewide analysis of H3K4me3 and H3K27me3
profiles in purified quiescent satellite cells and activated
satellite cells revealed a general lack of H3K27me3
repressive marker and the presence of H3K4me3 permis-
sive marker on a large number of genes in quiescent
satellite cells. Many non-myogenic-specific genes are
labeled by the bivalent histone marker in quiescent satellite
cells, which are replaced by the repressive H3K27me3
marker in activated satellite cells. The changes in the his-
tone modification status in activated satellite cells
compared with quiescent satellite cells may be due to the
significant increase in the PcG subunit Ezh2 [123].
Sirt1, a member of the NAD?-dependent protein
deacetylase family, is expressed in both quiescent and
activated satellite cells. The reduction of Sirt1 level leads
to premature differentiation [174], whereas its overex-
pression promotes satellite cell proliferation [175]. Sirt1
deacetylates MyoD and MEF2D to regulate their activities
[176, 177]. Sirt1 interacts with Notch signaling pathway
components Hes1 and Hey2 interfering with Notch activity
[178]. This may also contribute to control of satellite cell
activation (Fig. 1). Sirt1 can also serve as a nutrient sensor.
Sirt1 interacts with ATG7 to activate autophagy through
AMPK pathway. The activation of autophagic flux helps
meet the high bioenergetic demands of satellite cell acti-
vation [179].
DNA methylation in satellite cell activation
DNA methylation is an important aspect of epigenetic
regulation. More than three decades ago, it was demon-
strated that inhibition of DNA methylation
transdifferentiated fibroblasts to muscle lineage [180]. In
satellite cells, Dnmt-3b, a member of the DNA methyl-
transferase family, is recruited to CpG islands in Notch1
promoter in an Ezh2 binding-dependent manner to mediate
increased methylation of Notch1 promoter under the con-
trol of TNF-a and NF-jB. Hyper-DNA methylation of
Notch1 promoter mediated by TNF-a and NF-jB leads to a
reduction of satellite cell self-renewal and proliferation
[181]. The application of sulforaphane, a DNA methyl-
transferase inhibitor, to isolated satellite cells results in
downregulation of the myostatin signaling pathway, which
may promote satellite cell proliferation and differentiation
[182].
The importance of DNA methylation in regulating stem
cell functions has only begun to be unraveled in recent
years and the data accumulated so far are limited. The
current observations hint that DNA methylation might be
an additional aspect to regulate satellite cell activation, but
the direct link between satellite cell activation and DNA
methylation is still missing. More systematic investigations
are required to clarify the function of DNA methylation in
this process.
Non-coding RNA
Non-coding RNA (ncRNA) has been shown in the last
decade to act as key regulators of gene expression. NcRNA
makes up the majority of transcription products of the
eukaryotic genome. It can be divided into structural and
regulatory RNAs. Ribosomal RNA (rRNA), small nuclear
RNA (snRNA), small nucleolar RNA (snoRNA), and
tRNA are grouped as structural RNAs whose functions
have been thoroughly studied for decades. Small regulatory
RNA comprises microRNAs (miRNAs), piwi-interacting
RNAs (piRNAs), and small interfering RNAs (siRNAs).
Regulatory RNA molecules longer than 200 nucleotides
are characterized as long non-coding RNA (lncRNA)
[183]. In this review, we focus on the functions of miRNA
and lncRNA in the process of satellite cell activation.
Micro RNA
The myomiR family is a group of miRNAs specifically
expressed in muscle, including miR-1a, miR-133, miR-206,
miR-208, miR-486, and miR-499. The myomiR family is
involved in regulating muscle differentiation and is capable
of transdifferentiating fibroblasts to muscle lineage cells
[184]. miR-1 expression is upregulated during muscle
regeneration. It directly represses Pax7 expression to pro-
mote satellite cell proliferation and differentiation [185].
In addition to myomiRs, there are several other miRNAs
involved in satellite cell activation. Both miR-31 and the
mRNA of Myf5 are sequestered in ribonucleoprotein
(RNP) granules, where miR-31 interacts with the 3’ UTR
of Myf5 to suppress its translation in quiescent satellite
cells [44, 186]. Upon satellite cell activation, Myf5 mRNA
is released by downregulation of miR-31 and breakdown of
RNP granules to rapidly switch on Myf5 protein translation
[44, 186]. MiR-489 is enriched in quiescent satellite cells,
and downregulated in activated satellite cells. It represses
the expression of oncogene Dek to prevent quiescent
satellite cells from entering cell cycle [187]. MiR-181 is
upregulated during muscle regeneration. It targets Hox-
A11, a negative regulator of MyoD, to promote satellite
cell activation and differentiation [188]. MiR-206 is highly
upregulated in activated satellite cells and myoblasts. It is
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also highly expressed in Duchenne muscles probably due to
an intensified activation of satellite cells [186, 189–192].
Upregulation of miR-206 represses expression of Pax7,
Notch3, IGFBP5, and Hmgb3 to promote satellite cell
differentiation [193]. Downregulation of miR-125b occurs
after injury to relieve IGF2 repression and promote sub-
sequent satellite cell activation [194]. MiR-221/222 can
also regulate satellite cell activation by promoting cell
cycle progression [195, 196]. MiR-1192 can inhibit the
translation of HMGB1, which is highly expressed in
satellite cells and myoblasts, inducing the expression of
myogenic factors such as MyoD and myogenin [197, 198].
A global downregulation of miRNAs has been observed
in human satellite cells during the transition from quies-
cence to activation, in particular miR-106b, miR-25, miR-
29c, and miR-320c [199]. The functions of these miRNAs
remain to be elucidated.
LncRNA
LncRNA can be grouped into cis-acting RNA and trans-
acting RNA. Cis-acting RNA works in proximity to its
transcription sites, whereas trans-acting RNA works at
distinct loci. Both cis- and trans-acting lncRNA can recruit
chromatin remodeling factors to alter the local or overall
chromatin status to regulate transcription [200]. As the
majority of the studies on lncRNA have been performed in
C2C12 myoblast cell line, little is known about its func-
tions in satellite cells.
The majority of known lncRNA molecules in myoblasts,
such as Malat1, linc-MD1, SRA, Neat1, and YAM, are
upregulated upon myoblast differentiation and are required
for normal differentiation [201–207]. Linc-MD1 is located
13 kb upstream of pre-miR133b. Two microRNAs,
miR133b and miR206, are located in the gene body of linc-
MD1. Linc-MD1 fine-tunes the differentiation timing of
myoblasts by sponging miR133b and miR206 to antago-
nize their repression on MAML1 and MEF2C [207]. The
RNA-binding protein HuR binds linc-MD1 to facilitate the
accumulation of linc-MD1 in cells and reinforce its sponge
activity [201]. H19 is transcribed from the Igf2 locus and is
highly expressed in adult muscle [208–210]. It interacts
with PRC2 to repress the expression of Igf2, therefore
inhibiting proliferation [211, 212]. H19 has several let-7
binding sites and serves as a microRNA let-7 sponge to
relieve the inhibitory effects of let-7 on Igfbp2, an inhibitor
of the IGF signaling pathway [213]. In myoblasts, H19
downregulates IGF signaling pathway to repress prolifer-
ation and may also play a similarly negative role in IGF
signaling in satellite cells. To investigate the functions of
lncRNA in satellite cell activation, expression profiles and
functional assays should be carried out in quiescent and
activated satellite cells.
The functions of ncRNA are just beginning to be real-
ized. The specific functions of ncRNA during satellite cell
activation, in particular, whether it can directly drive
satellite cell activation, require further investigation.
Conclusion
The activation of quiescent satellite cells is orchestrated by
physiological cues, signaling pathways, and epigenetic
regulators. We are just beginning to unravel how this
process is regulated. Many questions remain unanswered,
especially with regard to transcription and epigenetic reg-
ulation. Satellite cell activation is an asynchronized and
transient process in vivo. Following the live cell activation
process by high-resolution imaging and other new tech-
niques will reveal more information about the process
in vivo. The identification of more key genetic mutants
affecting satellite cell activation will also help to reveal the
missing links in the regulatory network, while genomewide
analysis of the binding profile of epigenetic regulators will
further deepen our understanding.
Many factors have been found to exhibit dramatic
changes when satellite cells are activated. However, whe-
ther these changes are the causes of satellite cell activation
or the consequences of it remains to be identified. Genetic
mutations and careful characterization of the order of events
during the satellite cell activation process will shed light on
this. Another important question that remains to be explored
is the link between uncontrolled satellite cell activation and
cancer, especially non-alveolar rhabdomyosarcoma. Fur-
ther exploration of this question will reveal more targets for
drug development to treat rhabdomyosarcoma.
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